Module 11 UHC 2024

UNIVERSAL HEALTH CARE MODULE 11
The independent technical body duly authorized and delegated by the Secretary of Health to provide technical advice and
guidance to the DOH in implementing appropriate measures that promote and ensure access to affordable quality drugs and
medicines for all consumers in the Philippines:
a. Drug Price Advisory Council
A re-negotiation may be conducted as deemed appropriate by the end-user before the expiration of the Memorandum of
Agreement based on a set of criteria that includes the following:
a. All of the above are correct.
The DOH office responsible for the review of the medicines to be included in the Primary Care Formulary:
a. Health Technology Assessment Unit
The following is responsible to synthesize the data submitted by the end-user and Health Technology Assessment Council:
a. Price Negotiation Board Technical Working Group
The following statements are correct for successful outcomes of price negotiation, EXCEPT:
a. Companies are given fifteen (15) working days upon receipt of the decision of the Board to submit an appeal.
Ongoing expense of operating a business that cannot be conveniently traced to any particular cost unit:
a. Overhead cost
The following are true in the imposition of maximum retail price (MRP) on drugs and medicines:
a. Only B and C are correct.
The following statements are correct regarding the computation of retail prices for highly specialized drugs:
a. Only A and C are correct.
Drug or medical device that has been granted intellectual property rights, which provides a legal right to exclude others from
making, using, selling, and importing for a limited period of years:
a. Patented health commodity
The following are the objectives of the Administrative Order 2020-0043 (Guidelines on Ensuring the Affordability of Essential
Medicines in DOH Facilities Through the Regulation of Price Mark-ups):
The following are true regarding generic alternatives of drugs and medicines:
The following are the benefits of centralized price negotiation thru the Price Negotiation Board:
The following strategies are aimed to make price information of all health goods and services available and accessible, EXCEPT:
a. The prices and fees must be presented in a fixed amount.
The following are the criteria being used by the Drug Price Advisory Board for selecting drugs and medicines for consideration
under maximum retail pricing, EXCEPT:
a. Low price differential from other countries
Unit cost reflected in the Purchase Order which is the basis in the computation of price mark-ups:
a. Acquisition cost
As provided in the UHC Act, drugs and medicines listed in the Primary Care Formulary (PCF) shall have fairly priced generic
equivalents. The formulation of the PCF shall be based on:
a. Only A and C are correct
The following agencies must have representatives as members of the Price Negotiation Board, EXCEPT:
a. FDA
Drug or medical device that is used, produced, or marketed under exclusive legal right and protected by patent:
a. Proprietary health commodity
The following prerequisites and preparation apply for health commodities that are already listed in the Philippine National
Formulary:
a. Both B and C are correct
The prices of the following shall be included in the list of price information in all DOH-owned health facilities:
The following statements are true regarding the guidelines on public access to price information of all health goods and services
in DOH-owned health facilities:
a. Only A and B are correct.
In the implementation of price mark-ups in DOH-owned health facilities, the following is responsible to endorse to the
Commission on Audit any report of non-compliance observed by the Internal Audit Service:
a. DOH Pharmaceutical Division
The following statements are correct regarding price mark-ups of drugs and medicines in DOH-owned health facilities, EXCEPT:
a. Random monitoring of medicines prices shall be done regularly at DOH-owned facilities by the FDA.
Consumer’s guide that provides information on where to get the cheapest medicines within their area:
a. Drug Price Watch
The following statements are true regarding the appeal of any health facility whose license or accreditation is revoked or
suspended due to noncompliance to the provisions of Administrative Order 2021-008 on public access to price information of all
health goods and services, EXCEPT:
a. The decision of the Head of DOH HRT shall be final and executory.
Drug or medicine with an active pharmaceutical ingredient or molecule that was first originally marketed globally:
a. Comparator drug
The following statements are true regarding the composition of the Drug Price Advisory Board, EXCEPT:
a. The council members shall elect the chairperson.
The countries used as the basis for external reference pricing in determining the maximum retail price of drugs and medicines:
a. Only B, C, and D are correct.
The agency responsible to investigate alleged violations of Maximum Retail/Wholesale Price of drugs and medicines in
accordance with relevant laws:
a. Food and Drug Administration
In the implementation of Maximum Retail Price (MRP), the Department of Trade and Industry is responsible for:
a. Submission of quarterly price monitoring reports to the Secretary of Health

Module 11 UHC 2024

Uploaded by

Copyright:

Available Formats

Module 11 UHC 2024

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Module 11 UHC 2024

Uploaded by

Copyright:

Available Formats

UNIVERSAL HEALTH CARE MODULE 11

a. Drug Price Advisory Council

a. All of the above are correct.

a. Health Technology Assessment Unit

a. Price Negotiation Board Technical Working Group

a. Only B and C are correct.

a. Only A and C are correct.

a. Patented health commodity

a. All of the above are correct.

a. All of the above are correct.

a. All of the above are correct.

a. The prices and fees must be presented in a fixed amount.

a. Low price differential from other countries

a. Only A and C are correct

a. Proprietary health commodity

a. Both B and C are correct

a. All of the above are correct.

a. Only A and B are correct.

a. DOH Pharmaceutical Division

a. Drug Price Watch

a. The council members shall elect the chairperson.

a. Only B, C, and D are correct.

a. Food and Drug Administration

a. Submission of quarterly price monitoring reports to the Secretary of Health

You might also like